This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
British Journal of Cancer Open Access 07 May 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Pagès, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 391, 2128–2139 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. Immunoscore provides a more accurate prognosis. Nat Rev Clin Oncol 15, 471 (2018). https://doi.org/10.1038/s41571-018-0050-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-018-0050-y
This article is cited by
-
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
British Journal of Cancer (2020)
-
Immunoscore®: A Diagnostic Assay for Clinical Management of Colon Cancer
Molecular Diagnosis & Therapy (2020)